• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嘌呤能通路在肾透明细胞癌预后评估和临床应用中的潜在价值。

The potential value of the Purinergic pathway in the prognostic assessment and clinical application of kidney renal clear cell carcinoma.

机构信息

Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, Liaoning, China.

出版信息

Aging (Albany NY). 2024 Jan 4;16(1):246-266. doi: 10.18632/aging.205364.

DOI:10.18632/aging.205364
PMID:38180750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10817410/
Abstract

The Purinergic pathway is involved in a variety of important physiological processes in living organisms, and previous studies have shown that aberrant expression of the Purinergic pathway may contribute to the development of a variety of cancers, including kidney renal clear cell carcinoma (KIRC). The aim of this study was to delve into the Purinergic pathway in KIRC and to investigate its potential significance in prognostic assessment and clinical treatment. 33 genes associated with the Purinergic pathway were selected for pan-cancer analysis. Cluster analysis, targeted drug sensitivity analysis and immune cell infiltration analysis were applied to explore the mechanism of Purinergic pathway in KIRC. Using the machine learning process, we found that combining the Lasso+survivalSVM algorithm worked well for predicting survival accuracy in KIRC. We used LASSO regression to pinpoint nine Purinergic genes closely linked to KIRC, using them to create a survival model for KIRC. ROC survival curve was analyzed, and this survival model could effectively predict the survival rate of KIRC patients in the next 5, 7 and 10 years. Further univariate and multivariate Cox regression analyses revealed that age, grading, staging, and risk scores of KIRC patients were significantly associated with their prognostic survival and were identified as independent risk factors for prognosis. The nomogram tool developed through this study can help physicians accurately assess patient prognosis and provide guidance for developing treatment plans. The results of this study may bring new ideas for optimizing the prognostic assessment and therapeutic approaches for KIRC patients.

摘要

嘌呤能通路参与生物体的多种重要生理过程,先前的研究表明,嘌呤能通路的异常表达可能导致多种癌症的发生,包括肾透明细胞癌(KIRC)。本研究旨在深入探讨 KIRC 中的嘌呤能通路,并研究其在预后评估和临床治疗中的潜在意义。选择了 33 个与嘌呤能通路相关的基因进行泛癌症分析。通过聚类分析、靶向药物敏感性分析和免疫细胞浸润分析,探讨了嘌呤能通路在 KIRC 中的作用机制。利用机器学习过程,我们发现结合 Lasso+survivalSVM 算法可以很好地预测 KIRC 的生存准确性。我们使用 LASSO 回归筛选出 9 个与 KIRC 密切相关的嘌呤能基因,并用它们构建了 KIRC 的生存模型。进行了 ROC 生存曲线分析,该生存模型能够有效预测 KIRC 患者未来 5、7 和 10 年的生存率。进一步的单因素和多因素 Cox 回归分析表明,KIRC 患者的年龄、分级、分期和风险评分与预后生存显著相关,是预后的独立危险因素。通过本研究开发的列线图工具可以帮助医生准确评估患者的预后,并为制定治疗计划提供指导。本研究的结果可能为优化 KIRC 患者的预后评估和治疗方法带来新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/6e63c2309364/aging-16-205364-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/7c52fa2e1930/aging-16-205364-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/19a47aa01e5f/aging-16-205364-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/39789bd4068e/aging-16-205364-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/23e4e10fc397/aging-16-205364-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/da0a3059a066/aging-16-205364-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/80ee46395f11/aging-16-205364-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/6e63c2309364/aging-16-205364-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/7c52fa2e1930/aging-16-205364-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/19a47aa01e5f/aging-16-205364-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/39789bd4068e/aging-16-205364-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/23e4e10fc397/aging-16-205364-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/da0a3059a066/aging-16-205364-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/80ee46395f11/aging-16-205364-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f2a/10817410/6e63c2309364/aging-16-205364-g007.jpg

相似文献

1
The potential value of the Purinergic pathway in the prognostic assessment and clinical application of kidney renal clear cell carcinoma.嘌呤能通路在肾透明细胞癌预后评估和临床应用中的潜在价值。
Aging (Albany NY). 2024 Jan 4;16(1):246-266. doi: 10.18632/aging.205364.
2
Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.基于肾透明细胞癌中甲基化驱动基因的机器学习构建的新型预后预测模型。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20201604.
3
Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.构建并验证自噬相关长非编码 RNA 标志物用于预测肾透明细胞癌患者的预后
Cancer Med. 2021 Apr;10(7):2359-2369. doi: 10.1002/cam4.3820. Epub 2021 Mar 2.
4
Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.M7G 相关长链非编码 RNA 在肾透明细胞癌中的筛选及其潜在的诊断和预后作用。
BMC Urol. 2023 Nov 15;23(1):186. doi: 10.1186/s12894-023-01357-9.
5
Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.鉴定小分子药物并开发用于肾透明细胞癌的新型自噬相关预后标志物。
Cancer Med. 2020 Oct;9(19):7034-7051. doi: 10.1002/cam4.3367. Epub 2020 Aug 11.
6
An Investigation of SPC24 as a Putative Biomarker of Kidney Renal Clear Cell Carcinoma and Kidney Renal Papillary Cell Carcinoma for Predicting Prognosis and/or Immune Infiltration.SPC24 作为肾透明细胞癌和肾乳头状细胞癌的潜在生物标志物用于预测预后和/或免疫浸润的研究。
Comb Chem High Throughput Screen. 2022;25(13):2278-2294. doi: 10.2174/1386207325666220315105054.
7
A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1.FOX 家族的综合分析用于预测肾透明细胞癌的预后和 FOXG1 的致癌作用。
Aging (Albany NY). 2022 Dec 29;14(24):10107-10124. doi: 10.18632/aging.204448.
8
Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.N6-甲基腺苷相关长非编码 RNA 预后特征综合分析及其与肾透明细胞癌免疫浸润的相关性。
Crit Rev Eukaryot Gene Expr. 2022;32(1):79-98. doi: 10.1615/CritRevEukaryotGeneExpr.2021039325.
9
Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.与肾透明细胞癌癌症干细胞特性相关的可变剪接。
BMC Cancer. 2021 Jun 15;21(1):703. doi: 10.1186/s12885-021-08470-8.
10
Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma.二硫键相关长非编码 RNA 特征可预测肾透明细胞癌的预后。
Clin Genitourin Cancer. 2024 Aug;22(4):102095. doi: 10.1016/j.clgc.2024.102095. Epub 2024 Apr 18.

引用本文的文献

1
Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing.解析 ADAMs 在肝细胞癌临床异质性和免疫微环境中的作用:单细胞、空间转录组学和批量 RNA 测序的见解。
Front Immunol. 2024 Sep 13;15:1461424. doi: 10.3389/fimmu.2024.1461424. eCollection 2024.
2
Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformatics.基于生物信息学探讨 Eph/Ephrin 信号通路在胰腺癌中的预后和治疗价值。
Sci Rep. 2024 Jul 31;14(1):17650. doi: 10.1038/s41598-024-68385-9.

本文引用的文献

1
Integrating machine learning algorithms to systematically assess reactive oxygen species levels to aid prognosis and novel treatments for triple -negative breast cancer patients.将机器学习算法集成,以系统地评估活性氧水平,以帮助三阴性乳腺癌患者的预后和新的治疗方法。
Front Immunol. 2023 Jun 19;14:1196054. doi: 10.3389/fimmu.2023.1196054. eCollection 2023.
2
P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer.P2X1和P2X7受体过表达是肌层浸润性膀胱癌生存的负性预测指标。
Cancers (Basel). 2023 Apr 16;15(8):2321. doi: 10.3390/cancers15082321.
3
Dendritic cell subsets in cancer immunity and tumor antigen sensing.
树突状细胞亚群在癌症免疫和肿瘤抗原识别中的作用。
Cell Mol Immunol. 2023 May;20(5):432-447. doi: 10.1038/s41423-023-00990-6. Epub 2023 Mar 22.
4
Clear Cell Renal Cell Carcinoma: From Biology to Treatment.透明细胞肾细胞癌:从生物学特性到治疗方法
Cancers (Basel). 2023 Jan 21;15(3):665. doi: 10.3390/cancers15030665.
5
Purinergic signaling: Diverse effects and therapeutic potential in cancer.嘌呤能信号传导:在癌症中的多种作用及治疗潜力
Front Oncol. 2023 Jan 18;13:1058371. doi: 10.3389/fonc.2023.1058371. eCollection 2023.
6
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
7
An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer.一种外泌体相关的长非编码 RNA 风险模型可预测乳腺癌患者的生存结局。
Sci Rep. 2022 Dec 24;12(1):22322. doi: 10.1038/s41598-022-26894-5.
8
Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma.透明细胞肾细胞癌中酪氨酸激酶抑制剂耐药的分子机制。
Int J Urol. 2022 Dec;29(12):1419-1428. doi: 10.1111/iju.15042. Epub 2022 Sep 19.
9
Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance.嘌呤能受体是肿瘤代谢重编程的关键瓶颈:癌症治疗抵抗的主要嫌疑人。
Front Immunol. 2022 Aug 22;13:947885. doi: 10.3389/fimmu.2022.947885. eCollection 2022.
10
Differential molecular mechanistic behavior of HDACs in cancer progression.在癌症进展中 HDAC 的差异分子机制行为。
Med Oncol. 2022 Aug 16;39(11):171. doi: 10.1007/s12032-022-01770-4.